The shares of Johnson & Johnson (NYSE:JNJ) has been pegged with a rating of Equal Weight by Barclays in its latest research note that was published on January 23rd, 2019. The research company has also assigned a $135 price target. Barclays wasn’t the only research firm that published a report of Johnson & Johnson, with other equities research analysts also giving their opinion on the stock. Goldman advised investors in its research note published on July 12th, 2018, to Neutral the JNJ stock. The stock had earned Mkt Perform rating from Bernstein when it published its report on June 27th, 2018. That day the Bernstein set price target on the stock to $129. The stock was given Neutral rating by Citigroup in its report released on April 23rd, 2018, the day when the price target on the stock was placed at $134. Stifel was of a view that JNJ is Hold in its latest report on April 18th, 2018 while giving it a price target of $135. Stifel thinks that JNJ is worth Hold rating. This was contained in the firm’s report on January 24th, 2018 in which the stock’s price target was also moved to $145.
Amongst the analysts that rated the stock, 1 have recommended investors to sell it, 8 believe it has the potential for further growth, thus rating it as Hold while 5 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $144.67. The price of the stock the last time has raised by 16.99% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 71.42.
The shares of the company added by 0.21% during the trading session on Tuesday, reaching a low of $138.36 while ending the day at $138.77. During the trading session, a total of 6.43 million shares were traded which represents a 34.41% incline from the average session volume which is 9.80M shares. JNJ had ended its last session trading at 138.48. Johnson & Johnson currently has a market cap of $371.65B, while its P/E ratio stands at 24.74, while its P/E earnings growth sits at 4.56, with a beta of 0.66. Johnson & Johnson debt-to-equity ratio currently stands at 0.51, while its quick ratio hovers at 1.20. JNJ 52-week low price stands at $118.62 while its 52-week high price is $148.99.
The company in its last quarterly report recorded $1.97 earnings per share which is above the $1.95 predicted by most analysts. The Johnson & Johnson generated $20,394.00 million in revenue during the last quarter, which is slightly higher than the $20,198.80 million predicted by analysts. In the second quarter last year, the firm recorded $2.05 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -4.06%. Johnson & Johnson has the potential to record 5.61 EPS for the current fiscal year, according to equities analysts.
Investment analysts at SunTrust published a research note on October 25th, 2018 where it informed investors and clients that Vistra Energy Corp. (NYSE:VST) is now rated as Buy. Goldman also rated VST as Upgrade on July 12th, 2018, with its price target of $90 suggesting that VST could surge by 19.34% from its current share price. Even though the stock has been trading at $25.43/share, analysts expect it to surge higher by 0.20% to reach $31.59/share. It started the day trading at $25.705 and traded between $24.97 and $25.48 throughout the trading session.
A look at its technical shows that VST’s 50-day SMA is 24.62 while its 200-day SMA stands at 23.76. The company’s average trading volume currently stands at 3.99M shares, which means that the short-interest ratio is just 4.36 days. Over the past seven days, the company moved, with its shift of -3.04%. Looking further, the stock has raised 9.83% over the past 90 days while it gained 8.89% over the last six months.
The Vanguard Group Inc meanwhile sold more VST shares in the recently filed quarter, changing its stake to $926,315,257 worth of shares. Fidelity Management Research Co followed the path by increasing its VST portfolio by +58.07% in the quarter. This means that Fidelity Management Research Co bought 11,260,317 shares in the last quarter and now controls 30,650,030 shares of the VST stock, with the valuation hitting $769,622,253.
Similarly, Qatar Investment Authority decreased its Vistra Energy Corp. shares by 0.00% during the recently filed quarter. After selling 0 shares in the last quarter, the firm now controls 22,880,381 shares of Vistra Energy Corp. which are valued at $574,526,367. In the same vein, BlackRock Fund Advisors decreased its Vistra Energy Corp. shares by during the most recent reported quarter. The firm sold -137,120 shares during the quarter which decreased its stakes to 16,176,437 shares and is now valued at $406,190,333. Following these latest developments, around 0.20% of Vistra Energy Corp. stocks are owned by institutional investors and hedge funds.